SWK HOLDINGS CORP (SWKH)

Company Profile

SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company is headquartered in Dallas, Texas and currently employs 23 full-time employees. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers sophisticated, customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical-stage biopharmaceutical company offering formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform. This segment utilizes the technology platform to create a portfolio of royalty income.

Company Info

SWK HOLDINGS CORP

5956 Sherry Lane, Suite 650

Dallas TEXAS 75254

P: 12142177253

CEO: Winston L. Black

Employees: 23

Website: https://www.swkhold.com/